Findings | 1st stage (CT 0-3 days) | 2nd stage (CT 4-7 days) | 3rd stage (CT 8-14 days) | 4th stage (CT 15-21 days) | P value |
---|---|---|---|---|---|
Number of the patients | 82 | 67 | 71 | 73 | |
GGO | 52 (63.4%) a | 59 (88.1%) b | 60 (84.5%) b | 57 (78.1%) ab | #0.001* |
Crazy paving | 15 (18.3%) ab | 21 (31.3%) ab | 23 (32.4%) a | 10 (13.7%) b | #0.014* |
Consolidation | 14 (17.1%) a | 27 (40.3%) b | 45 (63.4%) c | 13 (17.8%) a | # < 0.001* |
Fibrosis | 0 (0.0%) a | 8 (11.9%) b | 24 (33.8%) c | 32 (43.8%) c | # < 0.001* |
CT Pattern | |||||
Pure GGO | 39 (47.6%) abc | 34 (50.7%) c | 20 (28.2%) b | 46 (63.0%) ac | § < 0.001* |
Consolidation | 1 (1.2%) a | 1 (1.5%) a | 5 (7.0%) a | 2 (2.7%) a | |
Mixed | 13 (15.9%) a | 25 (37.3%) b | 40 (56.3%) b | 11 (15.1%) a | |
Negative | 29 (35.4%) a | 7 (10.4%) b | 6 (8.5%) b | 14 (19.2%) ab | |
Mixed pattern | |||||
Predominant GGO | 6 (46.2%) | 13 (52.0%) | 9 (22.5%) | 5 (45.5%) | §0.069 |
Predominant Consolidation | 7 (53.8%) | 12 (48.0%) | 31 (77.5%) | 6 (54.5%) | |
Complications | 3 (3.7%) a | 3 (4.5%) a | 19 (27.1%) b | 3 (4.1%) a | # < 0.001* |
Types of complications | |||||
Hypoxia | 3 (3.7%) ab | 3 (4.5%) ab | 11 (15.7%) a | 1 (1.4%) b | §0.004* |
Pl. effusion | 0 (0.0%) a | 0 (0.0%) a | 13 (18.6%) b | 2 (2.7%) a | § < 0.001* |
Resp. distress | 0 (0.0%) | 0 (0.0%) | 2 (2.9%) | 0 (0.0%) | §0.105 |
Pneumothorax | 0 (0.0%) | 0 (0.0%) | 1 (1.4%) | 0 (0.0%) | §0.469 |
Number of the lobes affected | 2.0 ± 1.9 a | 3.3 ± 1.7 bc | 3.8 ± 1.6 c | 2.7 ± 1.8 ab | ^< 0.001* |
CT severity score | 2.4 ± 3.0 a | 5.2 ± 3.8 b | 7.1 ± 5.1 c | 3.7±3.5 ab | ^< 0.001* |
Oxygen saturation SpO2 % | 96.8 ± 2.2 a | 96.3 ± 2.0 a | 93.9 ± 3.7 b | 96.6±1.9 a | ^< 0.001* |